Colin B Rogers
Overview
Explore the profile of Colin B Rogers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weekman E, Rogers C, Sudduth T, Wilcock D
J Neuroinflammation
. 2025 Jan;
22(1):23.
PMID: 39885592
Over recent years, the retina has been increasingly investigated as a potential biomarker for dementia. A number of studies have looked at the effect of Alzheimer's disease (AD) pathology on...
2.
Niedowicz D, Wang W, Prajapati P, Zhong Y, Fister S, Rogers C, et al.
Brain Pathol
. 2024 Oct;
:e13312.
PMID: 39438022
Mutations in the human granulin (GRN) gene are associated with multiple diseases, including dementia disorders such as frontotemporal dementia (FTD) and limbic-predominant age-related TDP-43 encephalopathy (LATE). We studied a Grn...
3.
Frazier H, Braun D, Bailey C, Coleman M, Davis V, Dundon S, et al.
Brain Behav Immun Health
. 2024 Aug;
40:100826.
PMID: 39161874
Background: Inhibition of p38 alpha mitogen activated protein kinase (p38α) has shown great promise as a treatment for Alzheimer's disease (AD) in preclinical tests. However, previous preclinical studies were performed...
4.
Sziraki A, Zhong Y, Neltner A, Niedowicz D, Rogers C, Wilcock D, et al.
Neuropathol Appl Neurobiol
. 2023 Oct;
49(6):e12942.
PMID: 37812061
Aims: We sought to identify and optimise a universally available histological marker for pericytes in the human brain. Such a marker could be a useful tool for researchers. Further, identifying...
5.
Weekman E, Johnson S, Rogers C, Sudduth T, Xie K, Qiao Q, et al.
J Neuroinflammation
. 2023 Sep;
20(1):199.
PMID: 37658433
Background: Epidemiological data suggests statins could reduce the risk of dementia, and more specifically, Alzheimer's disease (AD). Pre-clinical data suggests statins reduce the risk of dementia through their pleiotropic effects...
6.
Braun D, Frazier H, Davis V, Coleman M, Rogers C, Van Eldik L
PLoS One
. 2023 May;
18(5):e0286495.
PMID: 37256881
The p38 alpha mitogen-activated protein kinase (p38α) is linked to both innate and adaptive immune responses and is under investigation as a target for drug development in the context of...
7.
Sompol P, Gollihue J, Weiss B, Lin R, Case S, Kraner S, et al.
J Neurosci
. 2023 Feb;
43(10):1797-1813.
PMID: 36746627
Despite the indispensable role that astrocytes play in the neurovascular unit, few studies have investigated the functional impact of astrocyte signaling in cognitive decline and dementia related to vascular pathology....
8.
Weekman E, Winder Z, Rogers C, Abner E, Sudduth T, Patel E, et al.
Alzheimers Dement (N Y)
. 2022 Dec;
8(1):e12368.
PMID: 36514441
Introduction: Vascular contributions to cognitive impairment and dementia (VCID) are a leading cause of dementia. An underappreciated, modifiable risk factor for VCID is hyperhomocysteinemia (HHcy), defined by elevated levels of...
9.
Shode F, Mahomed A, Rogers C
Phytochemistry
. 2002 Nov;
61(8):955-7.
PMID: 12453524
Two new phenolics, named typhaphthalide (a benzylphthalide) and typharin (an isocoumarin) plus sitosterol were isolated and identified from the hexane extract of the rhizomes of Typha capensis. The acetone extract...
10.
Methyl gardenolate A, a novel cycloartenoid ester from the leaves of Combretum woodii (Combretaceae)
Coombes P, Rogers C
Nat Prod Lett
. 2002 Nov;
16(5):301-4.
PMID: 12434984
Isolation of the novel cycloartenoid ester methyl gardenolate A (3a), together with gardenolic acid A (2a) and the unusual triterpenoid xi-glutinol (D:B-friedoolean-5-en-3xi-ol) (1a) from the leaves of Combretum woodii support...